Delivery Order SPE2DB20D1004-SPE2DB23FE8J6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,234.05 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,380.72, is for the delivery of Azelastine 0.1% (137 MCG) Spry 30ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
- This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Azelastine 0.1% (137 MCG) spray in 30ml bottles, with a ceiling value of $1,328.22 and a completion date of October 14, 2021. The contract is a firm fixed-price arrangement and was not set aside for any particular business type. Amerisourcebergen Drug Corp,...
- This federal contract award, with the ID SPE2DX15D1053|SPE2DX24F6PTE, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,149.81 firm fixed price delivery order is for the supply of azelastine 0.1% (137 mcg) spray in 30 ml containers. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary...
- This federal contract award is for the delivery of Azelastine 0.1% (137 MCG) Nasal Spray, 30ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a firm fixed-price delivery order with a ceiling value of $3,585.39 and an ultimate completion date of December 22, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,392.00 firm fixed price contract is for the supply of 4565433298 - Azelastine 0.1% (137 MCG) Spray, 30ML. It is not a set-aside contract. The delivery order is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
- This contract award (SPE2DB20D2104|SPE2DB22FS22R) is for the delivery of Azelastine 0.1% (137 MCG) nasal spray, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,005.24 and a performance period ending on March 29, 2022. The contract was not set aside for any specific business...
- The Defense Logistics Agency awarded a delivery order valued at $2,461.70 to AmerisourceBergen Drug Corp for the supply of Azelastine 0.1% (137 micrograms) nasal spray in 30-milliliter units. This competitively awarded, firm fixed-price delivery order was issued on January 7, 2026, with an ultimate completion date of January 8, 2026. The product will be delivered to the place of performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent...
- The Defense Logistics Agency awarded a $87 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply 4561911878 units of the 0.1% 137 mcg spray to the DLA under a one-day period of performance ending August 24, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the contract from its facilities in Conshohocken, Pennsylvania. The delivery order was issued...
- The Defense Logistics Agency awarded a $522,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. The prime contractor will provide 456,169,400 units of the 0.1% 137 mcg spray bottles packaged in 30ml quantities. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 3rd to August 4th, 2023. As a major provider of pharmaceuticals and medical supplies,...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FE8J6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,029.59 firm fixed-price delivery order is for the supply of Azelastine 0.1% (137 MCG) spray, a pharmaceutical product, with a completion date of November 8, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense and veteran healthcare programs globally. This contract award does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/7/22 |